Clinical Trial Update: Biomarker-guided rTMS for Treatment Resistant Depression [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating biomarker-guided repetitive transcranial magnetic stimulation for treatment-resistant depression is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Treatment-resistant Depression

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Treatment Resistant Depression, Major Depressive Disorder | Phase 3 | Status: RECRUITING